Skip to main content
Top
Published in: Journal of Gastroenterology 6/2009

01-06-2009 | Original Article—Liver, Pancreas, and Biliary Tract

A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis

Authors: Yoshiyuki Yamagishi, Hidetsugu Saito, Hirotoshi Ebinuma, Masahiro Kikuchi, Keisuke Ojiro, Hideaki Kanamori, Shinichiro Tada, Yoshinori Horie, Shinzo Kato, Toshifumi Hibi

Published in: Journal of Gastroenterology | Issue 6/2009

Login to get access

Abstract

Background/Aims

King’s College Hospital (KCH) criteria and the model for end-stage liver disease (MELD) score are useful and widely-employed prognostic markers for acute liver failure (ALF). We previously reported that liver atrophy is an important prognostic factor for ALF. The aim of the present study was to assess the value of liver volumetry and to generate a new prognostic formula.

Methods

Computed tomography-derived liver volume (CTLV) and standardized liver volume (SLV) of 30 adult ALF patients were calculated at the time of diagnosis. Patients were assigned to one of two groups: group A consisted of 13 patients who recovered without surgical intervention, and group B consisted of 17 patients who died due to liver failure or who underwent living donor liver transplantation (LDLT).

Results

The median CTLV/SLV ratios of groups A and B were 1.019 and 0.757, respectively (P = 0.0009). The difference was most significant (P = 0.0002) at the probability cutoff point of 0.80 for CTLV/SLV ratio; the sensitivity and specificity were 76.5% and 92.3%, respectively. Serum total bilirubin (TB) levels and CTLV/SLV ratio were selected as independent prognostic factors by multivariate analysis. A prognostic formula including volumetric analysis was established: Z = −2.3813 − [0.15234 × TB (mg/dl)] + [4.5734 × CTLV/SLV] (AUC = 0.87783, P = 0.0002).

Conclusions

The CTLV/SLV ratio is a very useful marker for predicting the prognosis of adult ALF. Our prognostic formula including only the CTLV/SLV ratio and TB is simple and useful and awaits validation in a future larger-scale prospective study.
Literature
1.
go back to reference Miwa S, Hashikura Y, Mita A, Kubota T, Chisuwa H, Nakazawa Y, et al. Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure. Hepatology. 1999;30:1521–6.PubMedCrossRef Miwa S, Hashikura Y, Mita A, Kubota T, Chisuwa H, Nakazawa Y, et al. Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure. Hepatology. 1999;30:1521–6.PubMedCrossRef
2.
go back to reference Uemoto S, Inomata Y, Sakurai T, Egawa H, Fujita S, Kiuchi T, et al. Living donor liver transplantation for fulminant hepatic failure. Transplantation. 2000;70:152–7.PubMed Uemoto S, Inomata Y, Sakurai T, Egawa H, Fujita S, Kiuchi T, et al. Living donor liver transplantation for fulminant hepatic failure. Transplantation. 2000;70:152–7.PubMed
3.
go back to reference Yoshiba M, Inoue K, Sekiyama K, Koh I. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs. 1996;20:1169–72.PubMedCrossRef Yoshiba M, Inoue K, Sekiyama K, Koh I. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs. 1996;20:1169–72.PubMedCrossRef
4.
go back to reference Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G, et al. Fulminant hepatitis and late onset hepatic failure in Japan. Hepatol Res. 2008;38:646–57.PubMedCrossRef Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G, et al. Fulminant hepatitis and late onset hepatic failure in Japan. Hepatol Res. 2008;38:646–57.PubMedCrossRef
5.
go back to reference Morioka D, Egawa H, Kasahara M, Ito T, Haga H, Takada Y, et al. Outcomes of adult-to-adult living donor liver transplantation: a single institution’s experience with 335 consecutive cases. Ann Surg. 2007;245:315–25.PubMedCrossRef Morioka D, Egawa H, Kasahara M, Ito T, Haga H, Takada Y, et al. Outcomes of adult-to-adult living donor liver transplantation: a single institution’s experience with 335 consecutive cases. Ann Surg. 2007;245:315–25.PubMedCrossRef
6.
go back to reference Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Gimson A, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology. 1990;11:49–53.PubMedCrossRef Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Gimson A, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology. 1990;11:49–53.PubMedCrossRef
7.
go back to reference Nunez-Martinez O, De la Cruz G, De Diego A, Molina J, Rincon D, Santos L, et al. Liver transplantation for fulminant and subfulminant hepatic failure. Transplant Proc. 2003;35:1855–6.PubMedCrossRef Nunez-Martinez O, De la Cruz G, De Diego A, Molina J, Rincon D, Santos L, et al. Liver transplantation for fulminant and subfulminant hepatic failure. Transplant Proc. 2003;35:1855–6.PubMedCrossRef
8.
go back to reference Sugawara Y, Kaneko J, Imamura H, Minagawa M, Kokudo N, Makuuchi M. Living donor liver transplantation for fulminant hepatic failure. Transplant Proc. 2002;34:3287–8.PubMedCrossRef Sugawara Y, Kaneko J, Imamura H, Minagawa M, Kokudo N, Makuuchi M. Living donor liver transplantation for fulminant hepatic failure. Transplant Proc. 2002;34:3287–8.PubMedCrossRef
9.
go back to reference The Japanese Liver Transplantation Society. Liver transplantation in Japan. Ishoku. 2007;41:599–608. (in Japanese). The Japanese Liver Transplantation Society. Liver transplantation in Japan. Ishoku. 2007;41:599–608. (in Japanese).
10.
go back to reference Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl. 2004;10:886–97.PubMedCrossRef Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl. 2004;10:886–97.PubMedCrossRef
11.
go back to reference Yamagishi Y, Saito H, Shimadu M, Hoshino K, Kobayashi H, Nakamoto N, et al. Intensive therapy for fulminant hepatic failure: importance of co-operation between physicians of internal medicine and transplantation surgery. Nippon Shokakibyo Gakkai Zasshi. 2002;99:1205–12. (in Japanese).PubMed Yamagishi Y, Saito H, Shimadu M, Hoshino K, Kobayashi H, Nakamoto N, et al. Intensive therapy for fulminant hepatic failure: importance of co-operation between physicians of internal medicine and transplantation surgery. Nippon Shokakibyo Gakkai Zasshi. 2002;99:1205–12. (in Japanese).PubMed
12.
go back to reference Sekido H, Matsuo K, Takeda K, Ueda M, Morioka D, Kubota T, et al. Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure. Transplant Proc. 2004;36:2355–6.PubMedCrossRef Sekido H, Matsuo K, Takeda K, Ueda M, Morioka D, Kubota T, et al. Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure. Transplant Proc. 2004;36:2355–6.PubMedCrossRef
13.
go back to reference Doria C, Mandala L, Scott VL, Gruttadauria S, Marino IR. Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a single-center experience. Dig Dis Sci. 2006;51:47–53.PubMedCrossRef Doria C, Mandala L, Scott VL, Gruttadauria S, Marino IR. Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a single-center experience. Dig Dis Sci. 2006;51:47–53.PubMedCrossRef
14.
go back to reference Camus C, Lavoue S, Gacouin A, Le Tulzo Y, Lorho R, Boudjema K, et al. Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med. 2006;32:1817–25.PubMedCrossRef Camus C, Lavoue S, Gacouin A, Le Tulzo Y, Lorho R, Boudjema K, et al. Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med. 2006;32:1817–25.PubMedCrossRef
15.
go back to reference O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.PubMed O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.PubMed
16.
go back to reference Tygstrup N, Ranek L. Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis. 1986;6:129–37.PubMedCrossRef Tygstrup N, Ranek L. Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis. 1986;6:129–37.PubMedCrossRef
17.
go back to reference Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–70.PubMedCrossRef Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–70.PubMedCrossRef
18.
go back to reference Kremers WK, van IJperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology. 2004;39:764–9.PubMedCrossRef Kremers WK, van IJperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology. 2004;39:764–9.PubMedCrossRef
19.
go back to reference Sekiyama K, Yoshiba M, Inoue K, Sugata F. Prognostic value of hepatic volumetry in fulminant hepatic failure. Dig Dis Sci. 1994;39:240–4.PubMedCrossRef Sekiyama K, Yoshiba M, Inoue K, Sugata F. Prognostic value of hepatic volumetry in fulminant hepatic failure. Dig Dis Sci. 1994;39:240–4.PubMedCrossRef
20.
go back to reference Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology. 1995;21:1317–21.PubMedCrossRef Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology. 1995;21:1317–21.PubMedCrossRef
21.
go back to reference Yamagishi Y, Saito H, Tada S, Horie Y, Kato S, Ishii H, et al. Value of computed tomography-derived estimated liver volume/standard liver volume ratio for predicting the prognosis of adult fulminant hepatic failure in Japan. J Gastroenterol Hepatol. 2005;20:1843–9.PubMedCrossRef Yamagishi Y, Saito H, Tada S, Horie Y, Kato S, Ishii H, et al. Value of computed tomography-derived estimated liver volume/standard liver volume ratio for predicting the prognosis of adult fulminant hepatic failure in Japan. J Gastroenterol Hepatol. 2005;20:1843–9.PubMedCrossRef
22.
go back to reference Suzuki H. Hepatitis A, fulminant hepatitis. In: 12th Inuyama symposium reports. Tokyo: Chugai Igakusya; 1982. p. 110–230 (in Japanese). Suzuki H. Hepatitis A, fulminant hepatitis. In: 12th Inuyama symposium reports. Tokyo: Chugai Igakusya; 1982. p. 110–230 (in Japanese).
23.
go back to reference Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008;47:1401–15.PubMedCrossRef Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008;47:1401–15.PubMedCrossRef
24.
go back to reference Sugihara J, Naito T, Ishiki Y, Murakami H, Uchimoto T, Koshino Y, et al. A multicenter study on the prognosis and indications of liver transplantation for fulminant hepatitis in Japan. Acta Hepatol Jpn. 2001;42:543–57. (in Japanese). Sugihara J, Naito T, Ishiki Y, Murakami H, Uchimoto T, Koshino Y, et al. A multicenter study on the prognosis and indications of liver transplantation for fulminant hepatitis in Japan. Acta Hepatol Jpn. 2001;42:543–57. (in Japanese).
25.
go back to reference Heymsfield SB, Fulenwider T, Nordlinger B, Barlow R, Sones P, Kutner M. Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med. 1979;90:185–7.PubMed Heymsfield SB, Fulenwider T, Nordlinger B, Barlow R, Sones P, Kutner M. Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med. 1979;90:185–7.PubMed
26.
go back to reference Katoonizadeh A, Decaestecker J, Wilmer A, Aerts R, Verslype C, Vansteenbergen W, et al. MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int. 2007;27:329–34.PubMedCrossRef Katoonizadeh A, Decaestecker J, Wilmer A, Aerts R, Verslype C, Vansteenbergen W, et al. MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int. 2007;27:329–34.PubMedCrossRef
27.
go back to reference Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King’s College Hospital criteria. Liver Transpl. 2007;13:814–21.PubMedCrossRef Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King’s College Hospital criteria. Liver Transpl. 2007;13:814–21.PubMedCrossRef
28.
go back to reference Nitta M, Hirasawa H, Oda S, Shiga H, Nakanishi K, Matsuda K, et al. Long-term survivors with artificial liver support in fulminant hepatic failure. Ther Apher. 2002;6:208–12.PubMedCrossRef Nitta M, Hirasawa H, Oda S, Shiga H, Nakanishi K, Matsuda K, et al. Long-term survivors with artificial liver support in fulminant hepatic failure. Ther Apher. 2002;6:208–12.PubMedCrossRef
29.
go back to reference Marcos A, Ham JM, Fisher RA, Olzinski AT, Shiffman ML, Sanyal AJ, et al. Emergency adult to adult living donor liver transplantation for fulminant hepatic failure. Transplantation. 2000;69:2202–5.PubMedCrossRef Marcos A, Ham JM, Fisher RA, Olzinski AT, Shiffman ML, Sanyal AJ, et al. Emergency adult to adult living donor liver transplantation for fulminant hepatic failure. Transplantation. 2000;69:2202–5.PubMedCrossRef
30.
go back to reference Abouna GJ. Emergency adult to adult living donor liver transplantation for fulminant hepatic failure—is it justifiable? Transplantation. 2001;71:1498–500.PubMedCrossRef Abouna GJ. Emergency adult to adult living donor liver transplantation for fulminant hepatic failure—is it justifiable? Transplantation. 2001;71:1498–500.PubMedCrossRef
31.
go back to reference Haussinger D. Fulminant liver failure: is living related liver transplantation justified with respect to donor risk? Transplant Proc. 2003;35:920–1.PubMedCrossRef Haussinger D. Fulminant liver failure: is living related liver transplantation justified with respect to donor risk? Transplant Proc. 2003;35:920–1.PubMedCrossRef
32.
go back to reference Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podesta LG, Villamil FG. MELD is superior to King’s college and Clichy’s criteria to assess prognosis in fulminant hepatic failure. Liver Transpl. 2007;13:822–8.PubMedCrossRef Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podesta LG, Villamil FG. MELD is superior to King’s college and Clichy’s criteria to assess prognosis in fulminant hepatic failure. Liver Transpl. 2007;13:822–8.PubMedCrossRef
33.
go back to reference Mochida S, Nakayama N, Matsui A, Nagoshi S, Fujiwara K. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. Hepatol Res. 2008;38:970–9.PubMedCrossRef Mochida S, Nakayama N, Matsui A, Nagoshi S, Fujiwara K. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. Hepatol Res. 2008;38:970–9.PubMedCrossRef
Metadata
Title
A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis
Authors
Yoshiyuki Yamagishi
Hidetsugu Saito
Hirotoshi Ebinuma
Masahiro Kikuchi
Keisuke Ojiro
Hideaki Kanamori
Shinichiro Tada
Yoshinori Horie
Shinzo Kato
Toshifumi Hibi
Publication date
01-06-2009
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 6/2009
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-009-0045-7

Other articles of this Issue 6/2009

Journal of Gastroenterology 6/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.